Trademark: 86891245
Word
BRENDA
Status
Dead
Status Code
606
Status Date
Monday, March 25, 2019
Serial Number
86891245
Mark Type
4000
Filing Date
Friday, January 29, 2016
Published for Opposition
Tuesday, December 27, 2016
Abandoned Date
Monday, March 25, 2019

Trademark Owner History
Ishihara Sangyo Kaisha, Ltd. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress.; veterinary preparations for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; pharameutical agents affecting digestive organs; pharmaceutical preparations for skin care for animals; medicines for veterinary purposes for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress

Trademark Events
Mar 25, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 25, 2019
Abandonment - No Use Statement Filed
Jul 28, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2018
Extension 3 Granted
Jul 26, 2018
Extension 3 Filed
Jul 26, 2018
Teas Extension Received
Feb 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2018
Extension 2 Granted
Feb 15, 2018
Extension 2 Filed
Feb 15, 2018
Teas Extension Received
Aug 12, 2017
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2017
Extension 1 Granted
Aug 10, 2017
Extension 1 Filed
Aug 10, 2017
Teas Extension Received
Feb 21, 2017
Noa E-Mailed - Sou Required From Applicant
Dec 27, 2016
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2016
Published For Opposition
Dec 7, 2016
Notification Of Notice Of Publication E-Mailed
Nov 20, 2016
Approved For Pub - Principal Register
Nov 18, 2016
Teas/Email Correspondence Entered
Nov 18, 2016
Correspondence Received In Law Office
Nov 18, 2016
Teas Response To Office Action Received
May 20, 2016
Notification Of Non-Final Action E-Mailed
May 20, 2016
Non-Final Action E-Mailed
May 20, 2016
Non-Final Action Written
May 15, 2016
Assigned To Examiner
Feb 3, 2016
New Application Office Supplied Data Entered In Tram
Feb 2, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24